Autografting with Philadelphia chromosome-negative mobilized hematopoietic progenitor cells in chronic myelogenous leukemia

Angelo M. Carella, Enrica Lerma, Maria T. Corsetti, Anna Dejana, Palmina Basta, Franca Vassallo, Monica Abate, Monica Soracco, Federica Benvenuto, Osvaldo Figari, Marina Podestà, Giovanna Piaggio, Raimondo Ferrara, Mario Sessarego, Caterina Parodi, Michele Pizzuti, Alessandra Rubagotti, Domenico Occhini, Francesco Frassoni

Research output: Contribution to journalArticle

Abstract

Intensive chemotherapy given in early chronic phase of chronic myelogenous leukemia (CML) has resulted in high numbers of circulating Philadelphia (Ph) chromosome-negative hematopoietic progenitor cells (HPC). We have autografted 30 consecutive patients with CML in chronic phase with HPC collected in this way to facilitate restoration of Ph-negative hematopoiesis in bone marrow after high-dose therapy. Hematopoietic recovery to greater than 0.5 x 109/L neutrophils and to greater than 25 x 109/L platelets occurred in all patients, a median of 13 (range, 9 to 32) days and 16 (range, 6 to 106) days postautograft, respectively. Regenerating marrow cells were Ph-negative in 16 (53%) patients and greater than 66% Ph-negative in 10 (33%) patients. Twenty-eight patients are alive 6 to 76 months (median, 24 months) after autografting. Three patients have developed blast crisis from which 2 have died. Eight patients are in complete cytogenetic remission at a median of 20 (range, 6 to 44) months with a median ratio BCR-ABL/ABL of 0.002 (range,

Original languageEnglish
Pages (from-to)1534-1539
Number of pages6
JournalBlood
Volume93
Issue number5
Publication statusPublished - Mar 1 1999

Fingerprint

Philadelphia Chromosome
Chemotherapy
Autologous Transplantation
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Chromosomes
Hematopoietic Stem Cells
Platelets
Restoration
Bone
Cells
Recovery
Leukemia, Myeloid, Chronic Phase
Bone Marrow
Blast Crisis
Hematopoiesis
Cytogenetics
Neutrophils
Blood Platelets
Drug Therapy

ASJC Scopus subject areas

  • Hematology

Cite this

Autografting with Philadelphia chromosome-negative mobilized hematopoietic progenitor cells in chronic myelogenous leukemia. / Carella, Angelo M.; Lerma, Enrica; Corsetti, Maria T.; Dejana, Anna; Basta, Palmina; Vassallo, Franca; Abate, Monica; Soracco, Monica; Benvenuto, Federica; Figari, Osvaldo; Podestà, Marina; Piaggio, Giovanna; Ferrara, Raimondo; Sessarego, Mario; Parodi, Caterina; Pizzuti, Michele; Rubagotti, Alessandra; Occhini, Domenico; Frassoni, Francesco.

In: Blood, Vol. 93, No. 5, 01.03.1999, p. 1534-1539.

Research output: Contribution to journalArticle

Carella, AM, Lerma, E, Corsetti, MT, Dejana, A, Basta, P, Vassallo, F, Abate, M, Soracco, M, Benvenuto, F, Figari, O, Podestà, M, Piaggio, G, Ferrara, R, Sessarego, M, Parodi, C, Pizzuti, M, Rubagotti, A, Occhini, D & Frassoni, F 1999, 'Autografting with Philadelphia chromosome-negative mobilized hematopoietic progenitor cells in chronic myelogenous leukemia', Blood, vol. 93, no. 5, pp. 1534-1539.
Carella AM, Lerma E, Corsetti MT, Dejana A, Basta P, Vassallo F et al. Autografting with Philadelphia chromosome-negative mobilized hematopoietic progenitor cells in chronic myelogenous leukemia. Blood. 1999 Mar 1;93(5):1534-1539.
Carella, Angelo M. ; Lerma, Enrica ; Corsetti, Maria T. ; Dejana, Anna ; Basta, Palmina ; Vassallo, Franca ; Abate, Monica ; Soracco, Monica ; Benvenuto, Federica ; Figari, Osvaldo ; Podestà, Marina ; Piaggio, Giovanna ; Ferrara, Raimondo ; Sessarego, Mario ; Parodi, Caterina ; Pizzuti, Michele ; Rubagotti, Alessandra ; Occhini, Domenico ; Frassoni, Francesco. / Autografting with Philadelphia chromosome-negative mobilized hematopoietic progenitor cells in chronic myelogenous leukemia. In: Blood. 1999 ; Vol. 93, No. 5. pp. 1534-1539.
@article{beed868b61524629a7e3d52e5ff557ef,
title = "Autografting with Philadelphia chromosome-negative mobilized hematopoietic progenitor cells in chronic myelogenous leukemia",
abstract = "Intensive chemotherapy given in early chronic phase of chronic myelogenous leukemia (CML) has resulted in high numbers of circulating Philadelphia (Ph) chromosome-negative hematopoietic progenitor cells (HPC). We have autografted 30 consecutive patients with CML in chronic phase with HPC collected in this way to facilitate restoration of Ph-negative hematopoiesis in bone marrow after high-dose therapy. Hematopoietic recovery to greater than 0.5 x 109/L neutrophils and to greater than 25 x 109/L platelets occurred in all patients, a median of 13 (range, 9 to 32) days and 16 (range, 6 to 106) days postautograft, respectively. Regenerating marrow cells were Ph-negative in 16 (53{\%}) patients and greater than 66{\%} Ph-negative in 10 (33{\%}) patients. Twenty-eight patients are alive 6 to 76 months (median, 24 months) after autografting. Three patients have developed blast crisis from which 2 have died. Eight patients are in complete cytogenetic remission at a median of 20 (range, 6 to 44) months with a median ratio BCR-ABL/ABL of 0.002 (range,",
author = "Carella, {Angelo M.} and Enrica Lerma and Corsetti, {Maria T.} and Anna Dejana and Palmina Basta and Franca Vassallo and Monica Abate and Monica Soracco and Federica Benvenuto and Osvaldo Figari and Marina Podest{\`a} and Giovanna Piaggio and Raimondo Ferrara and Mario Sessarego and Caterina Parodi and Michele Pizzuti and Alessandra Rubagotti and Domenico Occhini and Francesco Frassoni",
year = "1999",
month = "3",
day = "1",
language = "English",
volume = "93",
pages = "1534--1539",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "5",

}

TY - JOUR

T1 - Autografting with Philadelphia chromosome-negative mobilized hematopoietic progenitor cells in chronic myelogenous leukemia

AU - Carella, Angelo M.

AU - Lerma, Enrica

AU - Corsetti, Maria T.

AU - Dejana, Anna

AU - Basta, Palmina

AU - Vassallo, Franca

AU - Abate, Monica

AU - Soracco, Monica

AU - Benvenuto, Federica

AU - Figari, Osvaldo

AU - Podestà, Marina

AU - Piaggio, Giovanna

AU - Ferrara, Raimondo

AU - Sessarego, Mario

AU - Parodi, Caterina

AU - Pizzuti, Michele

AU - Rubagotti, Alessandra

AU - Occhini, Domenico

AU - Frassoni, Francesco

PY - 1999/3/1

Y1 - 1999/3/1

N2 - Intensive chemotherapy given in early chronic phase of chronic myelogenous leukemia (CML) has resulted in high numbers of circulating Philadelphia (Ph) chromosome-negative hematopoietic progenitor cells (HPC). We have autografted 30 consecutive patients with CML in chronic phase with HPC collected in this way to facilitate restoration of Ph-negative hematopoiesis in bone marrow after high-dose therapy. Hematopoietic recovery to greater than 0.5 x 109/L neutrophils and to greater than 25 x 109/L platelets occurred in all patients, a median of 13 (range, 9 to 32) days and 16 (range, 6 to 106) days postautograft, respectively. Regenerating marrow cells were Ph-negative in 16 (53%) patients and greater than 66% Ph-negative in 10 (33%) patients. Twenty-eight patients are alive 6 to 76 months (median, 24 months) after autografting. Three patients have developed blast crisis from which 2 have died. Eight patients are in complete cytogenetic remission at a median of 20 (range, 6 to 44) months with a median ratio BCR-ABL/ABL of 0.002 (range,

AB - Intensive chemotherapy given in early chronic phase of chronic myelogenous leukemia (CML) has resulted in high numbers of circulating Philadelphia (Ph) chromosome-negative hematopoietic progenitor cells (HPC). We have autografted 30 consecutive patients with CML in chronic phase with HPC collected in this way to facilitate restoration of Ph-negative hematopoiesis in bone marrow after high-dose therapy. Hematopoietic recovery to greater than 0.5 x 109/L neutrophils and to greater than 25 x 109/L platelets occurred in all patients, a median of 13 (range, 9 to 32) days and 16 (range, 6 to 106) days postautograft, respectively. Regenerating marrow cells were Ph-negative in 16 (53%) patients and greater than 66% Ph-negative in 10 (33%) patients. Twenty-eight patients are alive 6 to 76 months (median, 24 months) after autografting. Three patients have developed blast crisis from which 2 have died. Eight patients are in complete cytogenetic remission at a median of 20 (range, 6 to 44) months with a median ratio BCR-ABL/ABL of 0.002 (range,

UR - http://www.scopus.com/inward/record.url?scp=0033106286&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033106286&partnerID=8YFLogxK

M3 - Article

C2 - 10029581

AN - SCOPUS:0033106286

VL - 93

SP - 1534

EP - 1539

JO - Blood

JF - Blood

SN - 0006-4971

IS - 5

ER -